Recent events
Recent events tied to this brand in public sources.
Back to profile14 entries
2026
Evonik rejects BASF bid
Evonik rejected a BASF bid with sweetened terms valued at $12.5 billion.
2026
BASF raises offer for Evonik
BASF raised its offer for Evonik to over €11 billion, according to the headline.
2026
BASF approaches Evonik with merger proposal
BASF has approached rival Evonik with a merger proposal, according to a Financial Times report cited by Reuters.
2021
Evonik and Energiedienst receive the Energy Efficiency Award 2021
The German Energy Agency presented Evonik and Energiedienst with the Energy Efficiency Award 2021 for their joint waste heat project at Evonik’s Rheinfelden production site.
2021
Evonik expands organic dispersions capacity at Darmstadt
Evonik expanded production capacity for organic dispersions used in heat-sealing applications. An expanded plant at its Darmstadt site had been supplying additional material since the beginning of August.
2021
Evonik expands strategic partnership with BioNTech for vaccine lipids
Evonik and BioNTech expanded their strategic partnership to produce specialty lipids for COVID-19 vaccines at Evonik sites in Germany, with commercial quantities planned as early as the second half of 2021.
2020
Safic-Alcan announces Evonik functional silanes distribution partnership
Safic-Alcan announced that it would become Evonik’s distribution partner for several functional silanes in the Benelux and Nordic regions as of 1 January 2021.
2020
Evonik launches Eudratec Fasteric
Evonik launched Eudratec Fasteric, an oral drug delivery technology designed to provide enteric protection followed by rapid release in the upper small intestine.
2020
Evonik announces acquisition of Porocel
Evonik announced that it was acquiring Porocel Group for US$210 million to accelerate growth in its catalysts business. The transaction was expected to close by the end of 2020, subject to approval by relevant authorities.
2020
Evonik agrees to acquire innoHealth
Evonik concluded a purchase agreement to acquire biotechnology company innovativeHealth Group (innoHealth).
2020
Evonik announces fermentation-based collagen platform
Evonik announced the development of a collagen platform made through fermentation-based processes and without animal- or human-derived materials, for pharmaceutical, medical, cell culture and tissue engineering markets.
2019
Evonik announces ROHACELL production expansion in Alabama
Evonik announced an expansion of ROHACELL high-performance foam production at its Mobile, Alabama site. The expansion includes an additional production hall and is scheduled for completion in the fourth quarter of 2020.
2019
NXT Factory and Evonik form materials collaboration
NXT Factory formed a strategic collaboration with Evonik to expand the performance and reach of final-parts applications for customers using the QLS350 system.
2019
Firmenich acquires Evonik's carbon dioxide extraction business
Firmenich acquired Evonik's carbon dioxide extraction business. The acquired operation's products would be commercialized through Firmenich's ingredients business.